<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36633476</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2471-254X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Hepatology communications</Title><ISOAbbreviation>Hepatol Commun</ISOAbbreviation></Journal><ArticleTitle>Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.</ArticleTitle><Pagination><StartPage>e8874</StartPage><MedlinePgn>e8874</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e8874</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/01.HC9.0000897224.68874.de</ELocationID><Abstract><AbstractText Label="BACKGROUND">COVID-19 is associated with higher morbidity and mortality in patients with chronic liver diseases (CLDs). However, our understanding of the long-term outcomes of COVID-19 in patients with CLD is limited.</AbstractText><AbstractText Label="METHODS">We conducted a multicenter, observational cohort study of adult patients with CLD who were diagnosed with COVID-19 before May 30, 2020, to determine long-term clinical outcomes. We used a control group of patients with CLD confirmed negative for COVID-19.</AbstractText><AbstractText Label="RESULTS">We followed 666 patients with CLD (median age 58 years, 52.8% male) for a median of 384 (interquartile range: 31-462) days. The long-term mortality was 8.1%; with 3.6% experiencing delayed COVID-19-related mortality. Compared to a propensity-matched control group of patients with CLD without COVID-19 (n=1332), patients with CLD with COVID-19 had worse long-term survival [p&lt;0.001; hazards ratio (HR): 1.69; 95% CI: 1.19-2.41] and higher rate of hospitalization (p&lt;0.001, HR: 2.00, 1.62-2.48) over a 1-year follow-up period. Overall, 29.9% of patients reported symptoms of long-COVID-19. On multivariable analysis, female sex (p=0.05, HR: 2.45, 1.01-2.11), Hispanic ethnicity (p=0.003, HR: 1.94, 1.26-2.99), and severe COVID-19 requiring mechanical ventilation (p=0.028, HR: 1.74, 1.06-2.86) predicted long-COVID-19. In survivors, liver-related laboratory parameters showed significant improvement after COVID-19 resolution. COVID-19 vaccine status was available for 72% (n=470) of patients with CLD and history of COVID-19, of whom, 70% (n=326) had received the COVID-19 vaccine.</AbstractText><AbstractText Label="CONCLUSIONS">Our large, longitudinal, multicenter study demonstrates a high burden of long-term mortality and morbidity in patients with CLD and COVID-19. Symptoms consistent with long-COVID-19 were present in 30% of patients with CLD. These results illustrate the prolonged implications of COVID-19 both for recovering patients and for health care systems.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc on behalf of the American Association for the Study of Liver Diseases.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aby</LastName><ForeName>Elizabeth S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0002-1809-2658</Identifier><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moafa</LastName><ForeName>Ghady</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ochsner Medical Center, New Orleans, Louisiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latt</LastName><ForeName>Nyan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-5251-6573</Identifier><AffiliationInfo><Affiliation>Ochsner Medical Center, New Orleans, Louisiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sultan</LastName><ForeName>Mohammad T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Ochsner Medical Center, New Orleans, Louisiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cacioppo</LastName><ForeName>Paula A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Ochsner Medical Center, New Orleans, Louisiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sonal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Weill Cornell Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Raymond T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloom</LastName><ForeName>Patricia P</ForeName><Initials>PP</Initials><Identifier Source="ORCID">0000-0003-3188-7188</Identifier><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gustafson</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daidone</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinus</LastName><ForeName>Zoe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debes</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0002-1512-2604</Identifier><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandhu</LastName><ForeName>Sunny</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2530-5885</Identifier><AffiliationInfo><Affiliation>University of California San Francisco, Fresno, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohal</LastName><ForeName>Aalam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8365-7240</Identifier><AffiliationInfo><Affiliation>University of California San Francisco, Fresno, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalid</LastName><ForeName>Sameeha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9643-3473</Identifier><AffiliationInfo><Affiliation>University of California San Francisco, Fresno, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roytman</LastName><ForeName>Marina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3916-4278</Identifier><AffiliationInfo><Affiliation>University of California San Francisco, Fresno, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catana</LastName><ForeName>Andreea Maria</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-2075-0701</Identifier><AffiliationInfo><Affiliation>Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegermann</LastName><ForeName>Kara</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1024-9040</Identifier><AffiliationInfo><Affiliation>Duke University, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>Rotonya M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0003-0235-6994</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saiman</LastName><ForeName>Yedidya</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2279-760</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassab</LastName><ForeName>Ihab</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Vincent L</ForeName><Initials>VL</Initials><Identifier Source="ORCID">0000-0002-0157-6066</Identifier><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabiee</LastName><ForeName>Atoosa</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3535-2706</Identifier><AffiliationInfo><Affiliation>VA Medical Center, Washington, DC USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Carly</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-3359-2220</Identifier><AffiliationInfo><Affiliation>University of Arizona/BannerHealth, Tucson, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gainey</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2201-6009</Identifier><AffiliationInfo><Affiliation>University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Kali</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8554-2906</Identifier><AffiliationInfo><Affiliation>University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chavin</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0818-4847</Identifier><AffiliationInfo><Affiliation>University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lizaola-Mayo</LastName><ForeName>Blanca C</ForeName><Initials>BC</Initials><Identifier Source="ORCID">0000-0003-0130-0091</Identifier><AffiliationInfo><Affiliation>Mayo Clinic, Scottsdale, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chascsa</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0003-2972-6545</Identifier><AffiliationInfo><Affiliation>Mayo Clinic, Scottsdale, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varelas</LastName><ForeName>Lee</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2579-4092</Identifier><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghe</LastName><ForeName>Akshata</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhanasekaran</LastName><ForeName>Renumathy</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8819-7511</Identifier><AffiliationInfo><Affiliation>Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hepatol Commun</MedlineTA><NlmUniqueID>101695860</NlmUniqueID><ISSNLinking>2471-254X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="Y">Liver Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>PM received grants from Vedanta Biosciences. RMC advised AstraZeneca; received grants from Intercept and Merck. RC received grants from Gilead, AbbVie, Merck, Boehringer, Roche, Janssen, and GSK. MR advises Gilead and Intercept.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>12</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36633476</ArticleId><ArticleId IdType="pmc">PMC9827967</ArticleId><ArticleId IdType="doi">10.1097/01.HC9.0000897224.68874.de</ArticleId><ArticleId IdType="pii">02009842-202301010-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosey MM, Needham DM. Survivorship after COVID-19 ICU stay. Nat Rev Dis Primers. 2020;6:60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362322</ArticleId><ArticleId IdType="pubmed">32669623</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al. . Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4:e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. . Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4:e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, et al. . Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study. Clin Gastroenterol Hepatol. 2021;19:1469&#x2013;1479.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7497795</ArticleId><ArticleId IdType="pubmed">32950749</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabiee A, Sadowski B, Adeniji N, Perumalswami PV, Nguyen V, Moghe A, et al. . Liver injury in liver transplant recipients with coronavirus disease 2019 (COVID-19): US multicenter experience. Hepatology. 2020;72:1900&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537191</ArticleId><ArticleId IdType="pubmed">32964510</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeniji N, Carr RM, Aby ES, Catana AM, Wegermann K, Dhanasekaran R. Socioeconomic factors contribute to the higher risk of COVID-19 in racial and ethnic minorities with chronic liver diseases. Gastroenterology. 2021;160:1406&#x2013;1409.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7677694</ArticleId><ArticleId IdType="pubmed">33227281</ArticleId></ArticleIdList></Reference><Reference><Citation>Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, et al. . Outcome of COVID-19 in patients with autoimmune hepatitis: an international multicenter study. Hepatology. 2021;73:2099&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250536</ArticleId><ArticleId IdType="pubmed">33713486</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Health Statistics
Guidance for Certifying Deaths Due to Coronavirus Disease 2019 (COVID-19). 2020. March 2, 2022. Available at:
https://www.cdc.gov/nchs/data/nvss/vsrg/vsrg03-508.pdf.</Citation></Reference><Reference><Citation>Kasarala G, Tillmann HL. Standard liver tests. Clin Liver Dis. 2016;8:13&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6490189</ArticleId><ArticleId IdType="pubmed">31041056</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (hq) WH. A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021. March 2, 2022. Available at:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking Drinking Levels Defined. 2021. March 2, 2022. Available at:</Citation></Reference><Reference><Citation>Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX, et al. . Acute liver injury in COVID&#x2010;19: prevalence and association with clinical outcomes in a large US Cohort. Hepatology. 2020;72:807&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300739</ArticleId><ArticleId IdType="pubmed">32473607</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjot T, Webb GJ, Barritt AS, IV, Moon AM, Stamataki Z, Wong VW, et al. . COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021;18:348&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7945972</ArticleId><ArticleId IdType="pubmed">33692570</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: A Multicenter Research Network Study. Gastroenterology. 2020;159:768&#x2013;771.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196546</ArticleId><ArticleId IdType="pubmed">32376408</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainous AG, 3rd, Rooks BJ, Wu V, Orlando FA. COVID-19 post-acute sequelae among adults: 12 month mortality risk. Front Med (Lausanne). 2021;8:778434; Available at: 10.3389/fmed.2021.778434</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.778434</ArticleId><ArticleId IdType="pmc">PMC8671141</ArticleId><ArticleId IdType="pubmed">34926521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainous AG, III, Rooks BJ, Orlando FA. Risk of new hospitalization post-COVID-19 infection for non-COVID-19 conditions. J Am Board Fam Med. 2021;34:907&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">34535516</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nster C, Busse R, Spoden M, Rombey T, Schillinger G, Hoffmann W, et al. . 6-month mortality and readmissions of hospitalized COVID-19 patients: a nationwide cohort study of 8,679 patients in Germany. PLoS One. 2021;16:e0255427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8341502</ArticleId><ArticleId IdType="pubmed">34351975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj JS, Kamath PS, Reddy KR. The evolving challenge of infections in cirrhosis. Reply N Engl J Med. 2021;385:1151&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">34525296</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvaniti V, D&#x2019;Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, et al. . Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139:1246&#x2013;1256; 1256.e1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20558165</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E, Ritchie H, Rod&#xe9;s-Guirao L, Appel C, Gavrilov D, Giattino C, et al. . Coronavirus pandemic (COVID-19). Published online at OurWorldInData.org. 2022. March 2, 2022. Available at:
https://ourworldindata.org/coronavirus.</Citation></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021;75:e14357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. Covid-19: Middle aged women face greater risk of debilitating long term symptoms. BMJ. 2021;372:n829.</Citation><ArticleIdList><ArticleId IdType="pubmed">33766927</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutledge SM, Schiano TD, Florman S, Im GY. COVID-19 aftershocks on alcohol-associated liver disease: an early cross-sectional report from the US Epicenter. Hepatol Commun. 2021;5:1151&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013370</ArticleId><ArticleId IdType="pubmed">34533000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JU, Majid A, Judge R, Crook P, Nathwani R, Selvapatt N, et al. . Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder. Lancet Gastroenterol Hepatol. 2020;5:886&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403133</ArticleId><ArticleId IdType="pubmed">32763197</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon AM, Curtis B, Mandrekar P, Singal AK, Verna EC, Fix OK. Alcohol-associated liver disease before and after COVID-19&#x2014;an overview and call for ongoing investigation. Hepatol Commun. 2021;5:1616&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239751</ArticleId><ArticleId IdType="pubmed">34510833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellinger JL, Shedden K, Winder GS, Tapper E, Adams M, Fontana RJ, et al. . The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology. 2018;68:872&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">29579356</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini M, Ponzo V, Rosato R, Scumaci E, Goitre I, Benso A, et al. . Changes in Weight and Nutritional Habits in Adults with Obesity during the &#x201c;Lockdown&#x201d; Period Caused by the COVID-19 Virus Emergency. Nutrients. 2020;12:2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7400808</ArticleId><ArticleId IdType="pubmed">32645970</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim RG, Medina SP, Magee C, Khalili M. Fatty liver and the coronavirus disease 2019 pandemic: health behaviors, social factors, and telemedicine satisfaction in vulnerable populations. Hepatol Commun. 2022;6:1045&#x2013;1055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652883</ArticleId><ArticleId IdType="pubmed">34792300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: united states, 2017-2018. NCHS Data Brief. 2020;360:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32487284</ArticleId></ArticleIdList></Reference><Reference><Citation>John BV, Deng Y, Scheinberg A, Mahmud N, Taddei TH, Kaplan D, et al. . Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Intern Med. 2021;181:1306&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278308</ArticleId><ArticleId IdType="pubmed">34254978</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Benefits of getting a COVID-19 vaccine. Centers for Disease Control and Prevention. 2022. Available at:
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html</Citation></Reference><Reference><Citation>Khubchandani J, Macias Y. COVID-19 vaccination hesitancy in Hispanics and African-Americans: a review and recommendations for practice. Brain Behav Immun Health. 2021;15:100277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8137342</ArticleId><ArticleId IdType="pubmed">34036287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>